logo

For the Inventor, By the Inventor

New York, NY, United States of America

Hibercell, Inc.

Calculating rank
USPTO Granted Patents = 10


Trademarks = 1

Forward Citations = 2

Loading Chart...
Loading Chart...

35 inventors (with patents filed for the assignee):

goldMedal Edward A Kesicki (5 out of 9 patents)

silverMedal Aleksey I Gerasyuto (3 out of 25 patents)

bronzeMedal Nandita Bose (3 out of 12 patents)

4.  Johan Lindström (3 out of 3 patents)

5.  Lars Boukharta Persson (3 out of 5 patents)

6.  Jenny Viklund (3 out of 3 patents)

7.  Markus Kristofer Dahlgren (3 out of 8 patents)

8.  Eugene R Hickey (3 out of 66 patents)

9.  William J Grossman (2 out of 6 patents)

10.  Mary A Antonysamy (2 out of 6 patents)

11.  Richard M Walsh (2 out of 5 patents)

12.  Mariana I Nelson (2 out of 3 patents)

13.  Michael E Danielson (2 out of 20 patents)

14.  Kyle S Michel (2 out of 4 patents)

15.  Matthew Surman (2 out of 20 patents)


10 patents:

1. 12473296 - Perk inhibiting compounds (2025-11-18),
2. 12390526 - Methods for identifying beta-glucan binding to immune cells (2025-08-19),
3. 12331054 - Perk inhibiting imidazolopyrazine compounds (2025-06-17),
4. 12006332 - Aminopyrimidine derivatives as phosphatidylinositol phosphate kinase inhibitors (2024-06-11),
5. 11919902 - Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors (2024-03-05),
6. 11815435 - Beta glucan immunopharmacodynamics (2023-11-14),
7. 11667651 - Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors (2023-06-06),
8. 11584763 - Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors (2023-02-21),
9. 11498929 - Chromenopyrimidine derivatives as phosphatidylinsitol phosphate kinase inhibitors (2022-11-15),
10. 11229701 - Methods for identifying beta-glucan binding to immune cells (2022-01-25),
Company Overview
Hibercell, Inc. is a biotechnology company based in New York, specializing in the development of innovative therapeutics for the treatment of cancer and other diseases. The organization focuses on harnessing the power of cellular biology and advanced drug delivery systems to create targeted therapies that address unmet medical needs. With a commitment to scientific excellence, Hibercell aims to transform patient outcomes through its cutting-edge research and development efforts in the biopharmaceutical sector.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

10 Patents

#704 in New York, NY

#1,753 in New York

#29,944 in US

#56,228 in the World

New York, NY (US)
New York, NY, United States of America

Hibercell, Inc.

Forward Citations = 2

35 inventors:

goldMedal Edward A Kesicki (5 out of 9 patents)

silverMedal Aleksey I Gerasyuto (3 out of 25 patents)

bronzeMedal Nandita Bose (3 out of 12 patents)

4.  Johan Lindström (3 out of 3 patents)

5.  Lars Boukharta Persson (3 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Hibercell, Inc.. Retrieved from https://idiyas.com/company/hibercell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…